Skip to Primary Navigation Skip to Site Navigation Skip to Main Content

Early Stage Molecules

New pathways to improve vaccine efficacy

3M is working on developing a number of molecules that take advantage of activating different TLR pathways in the body to improve vaccine efficacy.

  • 853-Selective TLR8 agonist
  • New IRMs from 4 patent families
  • Molecules are in early preclinical stage

Contact Us for more information:

Contact Us

Contact Us
Exhibitions and Conferences

AAPS Biotechnology Conference
May 20-22, 2013
San Franscisco, CA

RDD Europe
May 20-24, 2013
Berlin, Germany

RDD Europe
May 21-24, 2013
Berlin, Germany


See all events